Article Sidebar

pdf
Date Published: 07/08/2024
Abstract Views: 133
Views pdf: 65
DOI: https://doi.org/10.51298/vmj.v541i1.10617
Issue
Vol. 541 No. 1 (2024)
Section
Các bài báo
How to Cite
Mai, T. K., Phạm, V. T., Phạm, V. T., Bùi, T. C., Nguyễn, T. L., Cao, V. T., Nguyễn, G. S., & Võ , T. H. T. (2024). EVALUATE THE TREATMENT EFFECTIVENESS OF DIFFERENT THYROID CANCER PATIENTS WITH I-131 AT CAN THO ONCOLOGY HOSPITAL. Vietnam Medical Journal, 541(1). https://doi.org/10.51298/vmj.v541i1.10617

EVALUATE THE TREATMENT EFFECTIVENESS OF DIFFERENT THYROID CANCER PATIENTS WITH I-131 AT CAN THO ONCOLOGY HOSPITAL

Trọng Khoa Mai, Văn Thái Phạm, Văn Thái Phạm, Tiến Công Bùi, Tấn Lực Nguyễn, Văn Trung Cao, Giang Sơn Nguyễn, Thị Huyền Trang Võ

Main Article Content

Abstract

Objective: To evaluate treatment effectiveness of different thyroid cancer patients with I-131 at Can Tho Oncology Hospital. Subjects and methods: A retrospective study of 257 differentiated thyroid cancer patients after surgery and treatment with radioactive iodine (RAI) from July 2016 to June 2022 at Can Tho Oncology Hospital. Results: The female/male ratio was 11/1, the mean age was 44.5 ± 11.8. The pathological results show that papillary thyroid carcinoma is the highest rate. Disease stage after surgery has the highest ratio is stage I. The complete response ratio after RAI is 75.9%. The overall survival after RAI is 86.7 ± 0.3 months. The 5-year survival rates after RAI is 99.6%.

Article Details

Keywords

Treatment effectiveness, differentiated thyroid cancer, I-131

References

L. Say, D. Chou, A. Gemmill et al (2014). Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health, 2 (6), e323-333.
2. Mai Trọng Khoa (2012). Đánh giá hiệu quả hủy mô tuyến giáp bằng I-131 trên bệnh nhân ung thư tuyến giáp thể biệt hóa sau phẫu thuật. Y học thực hành, 830, 69-73.
3. Đỗ Quang Trường và cộng sự (2011). Đánh giá hiệu quả hủy mô giáp còn lại sau phẫu thuật của I-131 ở bệnh nhân ung thư tuyến giáp thể biệt hóa. Y học thực hành, 12, 83-85.
4. W. Cheng, C. Ma, H. Fu et al (2013). Low- or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: a meta-analysis. J Clin Endocrinol Metab, 98 (4), 1353-1360.
5. Bùi Thanh Hùng (2018). Thời gian sống thêm ở bệnh nhân điều trị ung thư biểu mô tuyến giáp thể biệt hóa tại Bệnh viện Ung bướu Hà Nội. Tạp chí Y học Việt Nam, 471, 104 - 108.
6. A. F. Milano (2018). Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013. J Insur Med, 47 (3), 143-158.